About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Supreme Court Requests View of Solicitor General in American Axle v. Neapco | Main | BIO & IPO Issue Statements on Biden Administration's Support for Proposed WTO Waiver »

May 05, 2021

Comments

1) Until today, Brazil, the E.U., the U.K., & the U.S. all opposed a TRIPS waiver. Now that the U.S. backs a waiver, does that really change anything? That is to ask, will those others also change to match the U.S.? The E.U. & U.K. have their own domestic pharmaceutical industries to consider.

2) If one or more of the others stands against a waiver, can it pass? In theory WTO rules allow for majority vote, but usually the General Council prefers to work by unanimous consensus rather than majority rules.

3) What if—as seems very likely to me—the waiver passes and it makes no difference one way or another. When the U.S. CoC complains that “this move will undermine the global fight against COVID and it will diminish our ability to prepare for and respond to the next pandemic,” I rather wonder how this is supposed to happen. How will this diminish any abilities? How will the waiver change anything at all?

Mr. Delassus continues to ploy his "I don't see" - while clenching tight his eyes to any transfer of NON-patent know-how.

At this point, that has become beyond passe.

Evidently the EU is wobbly on this so far.

https://www.nytimes.com/2021/05/06/world/europe/coronavirus-vaccine-patent-eu.html

In the United States the Covid-129 vaccines are being paid for by US taxpayer dollars.
This a thoughtful and moral approach so that all people living in the US are protected while gradually knocking down the incidence of new Covid-19 infections in humans.

--------------------------
"Covid vaccines: How much they cost, who's bought them and ... SEE -
https://www.cnbc.com › 2020/11/17 › covid-vaccines-h...
Nov 17, 2020 — The cost of some of the leading coronavirus vaccine candidates ranges from $3 to $37. ... Two Covid-19 vaccines have been found to be highly effective in ... charging between $32 and $37 per dose for its vaccine for some customers. ... to manufacture between 500 million to 1 billion doses globally in 2021."
----------------------------
Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine SEE - https://www.nytimes.com/2021/05/04/business/pfizer-covid-vaccine-profits.html

The vaccine brought in $3.5 billion in revenue in the first three months of this year, nearly a quarter of its total revenue, Pfizer reported. The vaccine was, far and away, Pfizer’s biggest source of revenue.

The company did not disclose the profits it derived from the vaccine, but it reiterated its previous prediction that its profit margins on the vaccine would be in the high 20 percent range. That would translate into roughly $900 million in pretax vaccine profits in the first quarter.
---------------------------------------

I suggest there are at least three obvious other approaches instead of an IP waiver.
========================================
1. No IP Waiver occurs but big Pharma companies sell their vaccine at internationally cost of its manufacture or within a 5% instead of making a 20% profit for years 2021-2023? Each Foreign country pays the Pharma Company.
-------------------------------------
2. No IP waiver but the US government buys the Covid-19 vaccine doses and pays the Big Pharma companies a nil profit price which giving Big Pharma companies a Tax deduction. Then the US Government delivers the Covid-19 virus to all countries as Good Will for Free.
--------------------------------------

3. No IP waiver and Big Pharma continues to get current profits on the Covid-19 virus for year 2021 but then sells the vaccine at a price where the vaccine manufacturer makes a 5% profit and is compensated by a tax deduction.
------------------------------
4. No IP waiver anywhere in the world by any Covid-19 patenting, and all countries in the World donate free vaccine doses in their own countries paid by their governments taxes as in the US presently, and the Covid-19 countries donate free Covid 19 vaccine doses to countries that presently do not make the vaccine.
=============================

With any of these approaches, the IP waiver becomes unneeded.

It is a The countries seeking the waiver of IP protection for the vaccines do not want to pay for the vaccines.

Mr. Dresdner observes:

"It is [t]he countries seeking the waiver of IP protection for the vaccines do not want to pay for the vaccines."

Yes.

Clearly.

It was not ANY of the leading countries that ever came up with the idea of "Hey, let's wave ALL IP protections (and that clearly includes NON-patent IP)."

There is a larger game afoot. Not sure why this seems to escape the (same) people across the blogosphere...

The comments to this entry are closed.

October 2021

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31